Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2022

31-08-2021 | Endoscopy | Original Article

Enhanced Visibility in Evaluating Gastric Cancer and Helicobacter pylori-Associated Gastritis Using Linked Color Imaging with a Light-Emitting Diode Light Source

Authors: Tsugitaka Ishida, Osamu Dohi, Naohisa Yoshida, Takeshi Yasuda, Takuma Yoshida, Yuka Azuma, Hiroaki Kitae, Shinya Matsumura, Toshifumi Doi, Ryohei Hirose, Ken Inoue, Kazuhiro Kamada, Kazuhiko Uchiyama, Takeshi Ishikawa, Tomohisa Takagi, Hideyuki Konishi, Yuji Naito, Yoshito Itoh

Published in: Digestive Diseases and Sciences | Issue 6/2022

Login to get access

Abstract

Background

In Japan, laser light source (Laser) endoscopy is widely available, and the characteristics of light-emitting diode light source (LED) endoscopy have not been clarified.

Aims

We assessed the visibility of early gastric cancers (EGCs) and Helicobacter pylori (H. pylori)-associated gastritis for LED endoscopy compared with laser endoscopy using white-light imaging (WLI) and linked color imaging (LCI).

Methods

We assessed 99 lesions between February 2019 and March 2020. The visibility was scored from four (excellent visibility) to one (poor visibility) by evaluating videos including EGCs and gastric mucosa captured using WLI and LCI with LED endoscopy (LED-WLI and LED-LCI, respectively) and laser endoscopy (Laser-WLI and Laser-LCI, respectively). The primary end point was the non-inferiority of the visibility of EGCs and H. pylori-associated gastritis between LED-/Laser-WLI and LED-/Laser-LCI.

Results

The visibility scores of EGCs for LED-/Laser-WLI and LED-/Laser-LCI were 3.14/2.97 and 3.39/3.35, respectively. The visibility scores of H. pylori-associated gastritis [intestinal metaplasia (IM), diffuse redness (DR), regular arrangement of collecting venules (RAC) and map-like redness (MR)] for LED-/Laser-WLI and LED-/Laser-LCI were 3.05/2.85 and 3.60/3.50 (IM), 2.76/2.50 and 2.96/2.86 (DR), 2.69/2.44 and 2.77/2.62 (RAC) and 2.97/2.75 and 3.39/3.27 (MR). Non-inferiority was demonstrated for visualizing EGCs and H. pylori-associated gastritis.

Conclusions

LED-WLI and LED-LCI can be used to visualize EGCs and H. pylori-associated gastritis with non-inferiority to Laser-WLI and Laser-LCI. Furthermore, even with LED, LCI was more effective than WLI for evaluating EGCs and H. pylori-associated gastritis. Therefore, LED endoscopy can be used to detect EGCs and evaluate H. pylori-associated gastritis accurately.
Literature
1.
go back to reference Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–789.CrossRef Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–789.CrossRef
2.
go back to reference Masuyama H, Yoshitake N, Sasai T et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion. 2015;91:30–36.CrossRef Masuyama H, Yoshitake N, Sasai T et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion. 2015;91:30–36.CrossRef
3.
go back to reference Spence AD, Cardwell CR, McMenamin Ú et al. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review. BMC Gastroenterol. 2017;17:157.CrossRef Spence AD, Cardwell CR, McMenamin Ú et al. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review. BMC Gastroenterol. 2017;17:157.CrossRef
4.
go back to reference Sugano K, Tack J, Kuipers EJ et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–1367.CrossRef Sugano K, Tack J, Kuipers EJ et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–1367.CrossRef
5.
go back to reference Sugimoto M, Ban H, Ichikawa H et al. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer. Intern Med. 2017;56:579–586.CrossRef Sugimoto M, Ban H, Ichikawa H et al. Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer. Intern Med. 2017;56:579–586.CrossRef
6.
go back to reference Yoshii S, Mabe K, Watano K et al. Validity of endoscopic features for the diagnosis of Helicobacter pylori infection status based on the Kyoto classification of gastritis. Dig Endosc. 2020;32:74–83.CrossRef Yoshii S, Mabe K, Watano K et al. Validity of endoscopic features for the diagnosis of Helicobacter pylori infection status based on the Kyoto classification of gastritis. Dig Endosc. 2020;32:74–83.CrossRef
7.
go back to reference Dohi O, Majima A, Naito Y et al. Can image-enhanced endoscopy improve the diagnosis of Kyoto classification of gastritis in the clinical setting? Dig Endosc. 2020;32:191–203.CrossRef Dohi O, Majima A, Naito Y et al. Can image-enhanced endoscopy improve the diagnosis of Kyoto classification of gastritis in the clinical setting? Dig Endosc. 2020;32:191–203.CrossRef
8.
go back to reference Ono S, Dohi O, Yagi N et al. Accuracies of Endoscopic Diagnosis of Helicobacter pylori-Gastritis: Multicenter Prospective Study Using White Light Imaging and Linked Color Imaging. Digestion. 2020;101:624–630.CrossRef Ono S, Dohi O, Yagi N et al. Accuracies of Endoscopic Diagnosis of Helicobacter pylori-Gastritis: Multicenter Prospective Study Using White Light Imaging and Linked Color Imaging. Digestion. 2020;101:624–630.CrossRef
9.
go back to reference Takeda T, Asaoka D, Nojiri S et al. Linked Color Imaging and the Kyoto Classification of Gastritis: Evaluation of Visibility and Inter-Rater Reliability. Digestion. 2020;101:598–607.CrossRef Takeda T, Asaoka D, Nojiri S et al. Linked Color Imaging and the Kyoto Classification of Gastritis: Evaluation of Visibility and Inter-Rater Reliability. Digestion. 2020;101:598–607.CrossRef
10.
go back to reference Kaneko K, Oono Y, Yano T et al. Effect of novel bright image enhanced endoscopy using blue laser imaging (BLI). Endosc Int Open. 2014;2:E212–E219.CrossRef Kaneko K, Oono Y, Yano T et al. Effect of novel bright image enhanced endoscopy using blue laser imaging (BLI). Endosc Int Open. 2014;2:E212–E219.CrossRef
11.
go back to reference Fukuda H, Miura Y, Hayashi Y et al. Linked color imaging technology facilitates early detection of flat gastric cancers. Clin J Gastroenterol. 2015;8:385–389.CrossRef Fukuda H, Miura Y, Hayashi Y et al. Linked color imaging technology facilitates early detection of flat gastric cancers. Clin J Gastroenterol. 2015;8:385–389.CrossRef
12.
go back to reference Yoshifuku Y, Sanomura Y, Oka S et al. Evaluation of the visibility of early gastric cancer using linked color imaging and blue laser imaging. BMC Gastroenterol. 2017;17:150.CrossRef Yoshifuku Y, Sanomura Y, Oka S et al. Evaluation of the visibility of early gastric cancer using linked color imaging and blue laser imaging. BMC Gastroenterol. 2017;17:150.CrossRef
13.
go back to reference Dohi O, Yagi N, Naito Y et al. Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study. Gastrointest Endosc. 2010;89:47–57.CrossRef Dohi O, Yagi N, Naito Y et al. Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study. Gastrointest Endosc. 2010;89:47–57.CrossRef
14.
go back to reference Gao J, Zhang X, Meng Q et al. Linked color imaging can improve detection rate of early gastric cancer in a high-risk population: a multi-center randomized controlled clinical trial. Dig Dis Sci. 2021;66:1212–1219.CrossRef Gao J, Zhang X, Meng Q et al. Linked color imaging can improve detection rate of early gastric cancer in a high-risk population: a multi-center randomized controlled clinical trial. Dig Dis Sci. 2021;66:1212–1219.CrossRef
16.
go back to reference Majima A, Dohi O, Takayama S et al. Linked color imaging identifies important risk factors associated with gastric cancer after successful eradication of Helicobacter pylori. Gastrointest Endosc. 2019;90:763–769.CrossRef Majima A, Dohi O, Takayama S et al. Linked color imaging identifies important risk factors associated with gastric cancer after successful eradication of Helicobacter pylori. Gastrointest Endosc. 2019;90:763–769.CrossRef
17.
go back to reference Yoshida N, Dohi O, Inoue K et al. Blue Laser Imaging, Blue Light Imaging, and Linked Color Imaging for the Detection and Characterization of Colorectal Tumors. Gut Liver. 2019;13:140–148.CrossRef Yoshida N, Dohi O, Inoue K et al. Blue Laser Imaging, Blue Light Imaging, and Linked Color Imaging for the Detection and Characterization of Colorectal Tumors. Gut Liver. 2019;13:140–148.CrossRef
18.
go back to reference Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.
19.
go back to reference Yoshida N, Hisabe T, Hirose R et al. Improvement in the visibility of colorectal polyps by using blue laser imaging (with video). Gastrointest Endosc. 2015;82:542–549.CrossRef Yoshida N, Hisabe T, Hirose R et al. Improvement in the visibility of colorectal polyps by using blue laser imaging (with video). Gastrointest Endosc. 2015;82:542–549.CrossRef
20.
go back to reference Suzuki T, Hara T, Kitagawa Y et al. Linked-color imaging improves endoscopic visibility of colorectal nongranular flat lesions. Gastrointest Endosc. 2017;86:692–697.CrossRef Suzuki T, Hara T, Kitagawa Y et al. Linked-color imaging improves endoscopic visibility of colorectal nongranular flat lesions. Gastrointest Endosc. 2017;86:692–697.CrossRef
21.
go back to reference Kitagawa Y, Suzuki T, Hara T et al. Linked color imaging improves the endoscopic visibility of gastric mucosal cancers. Endosc Int Open. 2019;7:E164–E170.CrossRef Kitagawa Y, Suzuki T, Hara T et al. Linked color imaging improves the endoscopic visibility of gastric mucosal cancers. Endosc Int Open. 2019;7:E164–E170.CrossRef
22.
23.
go back to reference Gwet KL. Computing inter-rater reliability and its variance in the presence of high agreement. Br J Math Stat Psychol. 2008;61:29–48.CrossRef Gwet KL. Computing inter-rater reliability and its variance in the presence of high agreement. Br J Math Stat Psychol. 2008;61:29–48.CrossRef
24.
go back to reference Yoshida N, Naito Y, Yasuda R et al. Linked color imaging improves the visibility of various featured colorectal polyps in an endoscopist’s visibility and color difference value. Int J Colorectal Dis. 2017;32:1253–1260.CrossRef Yoshida N, Naito Y, Yasuda R et al. Linked color imaging improves the visibility of various featured colorectal polyps in an endoscopist’s visibility and color difference value. Int J Colorectal Dis. 2017;32:1253–1260.CrossRef
25.
go back to reference Takayama S, Dohi O, Naito Y et al. Diagnostic ability of magnifying blue light imaging with a light emitting diode light source for early gastric cancer: a prospective comparative study. Digestion. 2021;102:580–589.CrossRef Takayama S, Dohi O, Naito Y et al. Diagnostic ability of magnifying blue light imaging with a light emitting diode light source for early gastric cancer: a prospective comparative study. Digestion. 2021;102:580–589.CrossRef
Metadata
Title
Enhanced Visibility in Evaluating Gastric Cancer and Helicobacter pylori-Associated Gastritis Using Linked Color Imaging with a Light-Emitting Diode Light Source
Authors
Tsugitaka Ishida
Osamu Dohi
Naohisa Yoshida
Takeshi Yasuda
Takuma Yoshida
Yuka Azuma
Hiroaki Kitae
Shinya Matsumura
Toshifumi Doi
Ryohei Hirose
Ken Inoue
Kazuhiro Kamada
Kazuhiko Uchiyama
Takeshi Ishikawa
Tomohisa Takagi
Hideyuki Konishi
Yuji Naito
Yoshito Itoh
Publication date
31-08-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07234-5

Other articles of this Issue 6/2022

Digestive Diseases and Sciences 6/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.